Introduction
It has been estimated that the total diabetic patients in Bangladesh was more than 3 million in 2000, and this number would rise to 11.1 million by the 2030. The proportional increase in Bangladesh seemed relatively higher compared to other Asian countries 1 . An epidemiological study has revealed that the prevalence of DM in Bangladesh had increased exponentially in urban and rural populations which is double in urban than in
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secretory defect in Bangladeshi population 25 . In a recent study in Bangladesh, it was found that ratio of fasting glucose to adiponectin may be an important factor for the development of type 2 diabetes and associated with insulin sensitivity and insulin secretory capacity in prediabetic or IGR subjects 26 .
Based on the above findings and as serum adiponectin level has not yet been investigated in Bangladeshi T2DM subjects, this study has been under taken to find out the level of serum adiponectin in Bangladeshi T2DM subjects. Table 2 ). Median (range) serum adiponectin (µg/ml) of the control and T2DM subjects pancreas with consequent insulin deficiency to abnormalities that result in resistance to insulin action. Impairment of insulin secretion and defects in insulin action frequently coexist in the same patient, and it is often unclear which abnormality, if either alone, is the primary cause of the hyperglycemia 4 .
Material and Methods
Excess adiposity is one of the most important risk factor for the development of insulin resistance and type 2 diabetes 5 . Adipose tissue, in addition to being a fat store, secretes a number of hormones and proteins collectively termed adipokines 6, 7 . Of all the adipokines, adiponectin has drawn special attention, largely due to its effects on both insulin sensitivity and inflammation 8 .
In healthy nonobese subjects, the plasma level of adiponectin is 4-14 µg/ml 9,10 and according to Funahashi and Matsuzawa 11 , the concentration of adiponectin, ranges from 4 to 30 µg/mL in the blood.
Although the physiological role of adiponectin is yet to be determined, but it has been proposed that it has protective effects against the development of atherosclerosis 12, 13 and animal studies and cell culture experiments have shown that direct stimulation of nitric oxide synthesis is responsible for the anti-inflammatory mechanism and antiatherogenic effects of adiponectin 14 . Some found that administration of adiponectin decreased the attachment of monocytic cell to human aortic endothelial cells which is an early event in atherosclerotic vascular damage 13, 15 . These clinical and experimental observations suggest that adiponectin plays some protective role against the atherosclerotic vascular change and decreased plasma adiponectin in type 2 diabetic patients may contribute to the development of atherosclerotic complications 16 . Though adiponectin has no effect on normal insulin secretion, but diminishes the pro-apoptotic effects of cytokines and FFA on β-cells 16 . A prospective study shows that higher adiponectin levels are consistently associated with a lower risk of type 2 diabetes across diverse populations 17 . Low concentration of adiponectin predicted subsequent development of IGR and T2DM in initially normoglycemic middle aged people 18 .
Low adiponectin is shown to be predictive of future diabetes in many populations, including the Asian Indians 19, 20 . It is now established that, adiponectin is one of the strongest and most consistent biochemical predictors of type 2 diabetes 21 .
In a series of studies on Bangladeshi population to investigate the basic defects of T2DM both insulin secretory defect and insulin resistance had been found [22] [23] [24] . Another study has showed that T2DM have evidence of subclinical inflammation which is associated with insulin resistance but not with insulin was 8.70 (0.76-15.96) which was within normal range (4 -14 µg/ml) 9, 10 . This result was also compatible with only one study done in Bangladeshi population (1.9-19 µg/ml) 27. Lower limit of serum adiponectin level in this study was below the normal level of previous studies. It may be due to small sample size, age difference, BMI difference. The median (range) serum adiponectin (µg/ml) of the T2DM subjects was 6.19 (1.13-22.37 ). This result was consistent with the other studies 9, 10 . This result was also compatible with IGR population in Bangladesh 27 . Serum adiponectin level of T2DM subjects was significantly lower than the control subjects (p=0.0001). It indicates that low serum adiponectin level is associated with T2DM in Bangladeshi population. From group difference analysis it seems evident that serum adiponectin has an inverse association with T2DM which indicates serum adiponectin level is inversely associated with T2DM. This finding was consistent with other studies 28, 29, 30, 32 . Median HOMA%B of T2DM group was significantly lower than the control subjects (p=0.0001). It indicates T2DM subjects in this study have insulin secretory defects. The median HOMA%S of T2DM subjects was significantly lower than the control subjects (p=0.036). The median (range) HOMA IR of control and T2DM subjects were 3.49(0.46-11.43) and 5.77(1.0-28.34).
The median HOMA IR of T2DM subjects was significantly higher than the control subjects (P=0.0001). These findings indicate T2DM subjects in this study have insulin resistance. Impairment of insulin secretion and defects in insulin action frequently coexist in the same T2DM patients 4 .
Conclusions
From the findings of this study, it may be concluded that T2DM subjects have both insulin secretory defects and insulin resistance; and serum adiponectin level was significantly lower in T2DM subjects in Bangladeshi population. (Fig 1) . Serum adiponectin was significantly lower in T2DM compared to the control (p=0.0001). 
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